vs
Ameren（AEE）与奥尼兰姆制药（ALNY）财务数据对比。点击上方公司名可切换其他公司
Ameren的季度营收约是奥尼兰姆制药的1.6倍（$1.8B vs $1.1B），奥尼兰姆制药净利率更高（17.0% vs 14.2%，领先2.8%），奥尼兰姆制药同比增速更快（84.9% vs -8.2%），奥尼兰姆制药自由现金流更多（$140.3M vs $-54.0M），过去两年奥尼兰姆制药的营收复合增速更高（49.0% vs -0.9%）
Ameren Corporation是美国公共事业控股企业，下设Ameren密苏里、伊利诺伊州配电、伊利诺伊州天然气、输电四大业务板块，主营受费率监管的发电、输电、配电业务，以及受监管的天然气输配业务，电力生产主要采用煤炭、核电等能源。
奥尼兰姆制药是美国生物制药企业，2002年成立，总部位于马萨诸塞州剑桥市，专注于研发及商业化针对基因明确疾病的RNA干扰（RNAi）疗法，2016年入选福布斯「100家最具创新力成长企业」榜单。
AEE vs ALNY — 直观对比
营收规模更大
AEE
是对方的1.6倍
$1.1B
营收增速更快
ALNY
高出93.1%
-8.2%
净利率更高
ALNY
高出2.8%
14.2%
自由现金流更多
ALNY
多$194.3M
$-54.0M
两年增速更快
ALNY
近两年复合增速
-0.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.8B | $1.1B |
| 净利润 | $253.0M | $186.4M |
| 毛利率 | — | 75.6% |
| 营业利润率 | 20.2% | 12.0% |
| 净利率 | 14.2% | 17.0% |
| 营收同比 | -8.2% | 84.9% |
| 净利润同比 | 21.6% | 322.6% |
| 每股收益（稀释后） | $0.92 | $1.44 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AEEALNY
| Q4 25 | $1.8B | $1.1B | ||
| Q3 25 | $2.7B | $1.2B | ||
| Q2 25 | $2.2B | $773.7M | ||
| Q1 25 | $2.1B | $594.2M | ||
| Q4 24 | $1.9B | $593.2M | ||
| Q3 24 | $2.2B | $500.9M | ||
| Q2 24 | $1.7B | $659.8M | ||
| Q1 24 | $1.8B | $494.3M |
净利润AEEALNY
| Q4 25 | $253.0M | $186.4M | ||
| Q3 25 | $641.0M | $251.1M | ||
| Q2 25 | $277.0M | $-66.3M | ||
| Q1 25 | $290.0M | $-57.5M | ||
| Q4 24 | $208.0M | $-83.8M | ||
| Q3 24 | $457.0M | $-111.6M | ||
| Q2 24 | $260.0M | $-16.9M | ||
| Q1 24 | $262.0M | $-65.9M |
毛利率AEEALNY
| Q4 25 | — | 75.6% | ||
| Q3 25 | — | 84.2% | ||
| Q2 25 | — | 81.6% | ||
| Q1 25 | — | 88.2% | ||
| Q4 24 | — | 82.7% | ||
| Q3 24 | — | 83.6% | ||
| Q2 24 | — | 89.8% | ||
| Q1 24 | — | 89.0% |
营业利润率AEEALNY
| Q4 25 | 20.2% | 12.0% | ||
| Q3 25 | 30.6% | 29.5% | ||
| Q2 25 | 18.5% | -2.1% | ||
| Q1 25 | 20.5% | 3.0% | ||
| Q4 24 | 10.2% | -17.7% | ||
| Q3 24 | 27.0% | -15.4% | ||
| Q2 24 | 21.3% | 7.4% | ||
| Q1 24 | 20.4% | -8.8% |
净利率AEEALNY
| Q4 25 | 14.2% | 17.0% | ||
| Q3 25 | 23.7% | 20.1% | ||
| Q2 25 | 12.5% | -8.6% | ||
| Q1 25 | 13.8% | -9.7% | ||
| Q4 24 | 10.7% | -14.1% | ||
| Q3 24 | 21.0% | -22.3% | ||
| Q2 24 | 15.4% | -2.6% | ||
| Q1 24 | 14.4% | -13.3% |
每股收益（稀释后）AEEALNY
| Q4 25 | $0.92 | $1.44 | ||
| Q3 25 | $2.35 | $1.84 | ||
| Q2 25 | $1.01 | $-0.51 | ||
| Q1 25 | $1.07 | $-0.44 | ||
| Q4 24 | $0.77 | $-0.66 | ||
| Q3 24 | $1.70 | $-0.87 | ||
| Q2 24 | $0.97 | $-0.13 | ||
| Q1 24 | $0.98 | $-0.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $13.0M | $1.7B |
| 总债务越低越好 | $19.4B | — |
| 股东权益账面价值 | $13.4B | $789.2M |
| 总资产 | $48.5B | $5.0B |
| 负债/权益比越低杠杆越低 | 1.45× | — |
8季度趋势，按日历期对齐
现金及短期投资AEEALNY
| Q4 25 | $13.0M | $1.7B | ||
| Q3 25 | $9.0M | $1.5B | ||
| Q2 25 | $11.0M | $1.1B | ||
| Q1 25 | $23.0M | $1.0B | ||
| Q4 24 | $7.0M | $966.4M | ||
| Q3 24 | $17.0M | $1.1B | ||
| Q2 24 | $19.0M | $968.5M | ||
| Q1 24 | $85.0M | $681.9M |
总债务AEEALNY
| Q4 25 | $19.4B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $17.8B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AEEALNY
| Q4 25 | $13.4B | $789.2M | ||
| Q3 25 | $12.8B | $233.9M | ||
| Q2 25 | $12.3B | $250.6M | ||
| Q1 25 | $12.2B | $115.4M | ||
| Q4 24 | $12.1B | $67.1M | ||
| Q3 24 | $11.8B | $32.4M | ||
| Q2 24 | $11.5B | $-3.1M | ||
| Q1 24 | $11.4B | $-219.3M |
总资产AEEALNY
| Q4 25 | $48.5B | $5.0B | ||
| Q3 25 | $47.4B | $4.9B | ||
| Q2 25 | $46.6B | $4.6B | ||
| Q1 25 | $45.7B | $4.2B | ||
| Q4 24 | $44.6B | $4.2B | ||
| Q3 24 | $43.3B | $4.2B | ||
| Q2 24 | $42.3B | $4.0B | ||
| Q1 24 | $41.3B | $3.8B |
负债/权益比AEEALNY
| Q4 25 | 1.45× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.47× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $956.0M | $163.6M |
| 自由现金流经营现金流 - 资本支出 | $-54.0M | $140.3M |
| 自由现金流率自由现金流/营收 | -3.0% | 12.8% |
| 资本支出强度资本支出/营收 | 56.7% | 2.1% |
| 现金转化率经营现金流/净利润 | 3.78× | 0.88× |
| 过去12个月自由现金流最近4个季度 | $-775.0M | $465.4M |
8季度趋势，按日历期对齐
经营现金流AEEALNY
| Q4 25 | $956.0M | $163.6M | ||
| Q3 25 | $1.1B | $325.1M | ||
| Q2 25 | $862.0M | $153.7M | ||
| Q1 25 | $431.0M | $-118.3M | ||
| Q4 24 | $817.0M | $-94.7M | ||
| Q3 24 | $897.0M | $43.7M | ||
| Q2 24 | $557.0M | $124.2M | ||
| Q1 24 | $492.0M | $-81.5M |
自由现金流AEEALNY
| Q4 25 | $-54.0M | $140.3M | ||
| Q3 25 | $116.0M | $313.0M | ||
| Q2 25 | $-204.0M | $139.4M | ||
| Q1 25 | $-633.0M | $-127.3M | ||
| Q4 24 | $-473.0M | $-103.8M | ||
| Q3 24 | $-240.0M | $39.5M | ||
| Q2 24 | $-445.0M | $116.1M | ||
| Q1 24 | $-398.0M | $-94.5M |
自由现金流率AEEALNY
| Q4 25 | -3.0% | 12.8% | ||
| Q3 25 | 4.3% | 25.1% | ||
| Q2 25 | -9.2% | 18.0% | ||
| Q1 25 | -30.2% | -21.4% | ||
| Q4 24 | -24.4% | -17.5% | ||
| Q3 24 | -11.0% | 7.9% | ||
| Q2 24 | -26.3% | 17.6% | ||
| Q1 24 | -21.9% | -19.1% |
资本支出强度AEEALNY
| Q4 25 | 56.7% | 2.1% | ||
| Q3 25 | 36.6% | 1.0% | ||
| Q2 25 | 48.0% | 1.8% | ||
| Q1 25 | 50.7% | 1.5% | ||
| Q4 24 | 66.5% | 1.5% | ||
| Q3 24 | 52.3% | 0.8% | ||
| Q2 24 | 59.2% | 1.2% | ||
| Q1 24 | 49.0% | 2.6% |
现金转化率AEEALNY
| Q4 25 | 3.78× | 0.88× | ||
| Q3 25 | 1.72× | 1.29× | ||
| Q2 25 | 3.11× | — | ||
| Q1 25 | 1.49× | — | ||
| Q4 24 | 3.93× | — | ||
| Q3 24 | 1.96× | — | ||
| Q2 24 | 2.14× | — | ||
| Q1 24 | 1.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AEE
暂无分部数据
ALNY
| TTR | $858.3M | 78% |
| Rare | $136.4M | 12% |
| GIVLAARI | $56.3M | 5% |
| Collaborative Arrangement | $40.9M | 4% |
| ONPATTRO | $12.0M | 1% |
